Glaxo Wellcome to tender Zyban launch campaign

Glaxo Wellcome will hear pitches at the end of this year for an account to mount the PR launch of its first smoking cessation product, Zyban.

Glaxo Wellcome will hear pitches at the end of this year for an

account to mount the PR launch of its first smoking cessation product,

Zyban.



The drug, claimed to help people stop smoking, stay happy and lose

weight, has been billed in the media as potentially bigger than

Viagra.



But Glaxo Wellcome communications manager Philip Thompson said the

company was keen to avoid over-hyping the product as a ’wonder’

drug.



’We are looking for a consumer and healthcare campaign, issues

management and strong media relations,’ said Thompson.



CPR Worldwide was appointed earlier this year to run an anti-smoking

campaign across Europe, aimed at consumers and government, in the run-up

to the drug’s launch (PR Week, 4 May).



Manning Selvage and Lee and Cohn and Wolfe are known to have pitched for

the work.



Currently awaiting licensing from the European and UK regulatory

authorities, Glaxo Wellcome expects to launch Zyban in the UK next

year.



Zyban has been launched in the US, Canada and Mexico and, according to

the firm, has helped more than one million people quit smoking.



Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury to reconvene tomorrow after majority verdicts direction

Max Clifford trial jury to reconvene tomorrow after majority verdicts direction

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home for the day after being told by the judge earlier this afternoon that he will now accept majority verdicts.

Labour "fooling themselves" over plans to combat attacks on Miliband

Labour "fooling themselves" over plans to combat attacks on Miliband

Conservative-leaning public affairs experts have questioned the value of Labour's adoption of US-style campaigning tactics in the wake of the opposition hiring election strategist David Axelrod.

PLMR appoints Professor Tim Morris as non-executive director

The vet who helped establish the British Horseracing Authority's anti-doping and animal welfare programme has joined PLMR as a non-executive director.